Kininogen 1 (KNG1) Peptide
KNG1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN936168
Quick Overview for Kininogen 1 (KNG1) Peptide (ABIN936168)
Target
KNG1
(Kininogen 1 (KNG1))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- YPGKDFVQPP TKICVGCPRD IPTNSPELEE TLTHTITKLN AENNATFYFK
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KNG1 antibody,
Alternative Names: KNG1 control peptide, KNG1 antibody Blocking Peptide, Anti-KNG1 Blocking Peptide, Kininogen 1 Blocking Peptide, BDK Blocking Peptide, KNG Blocking Peptide, KNG1, KNG-1, KNG 1, KNG-1 Blocking Peptide, KNG 1 Blocking Peptide
-
-
Kininogen 1 (KNG1) peptide (BSA)
KNG1 Reactivity: Human Host: Synthetic WB, Imm, SDS
Kininogen 1 (KNG1) peptide (Ovalbumin)KNG1 Reactivity: Human Host: Synthetic WB, Imm, SDS
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- KNG1 (Kininogen 1 (KNG1))
-
Background
- Kininogens are inhibitors of thiol proteases. HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII and inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. The active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects such as influence in smooth muscle contraction, induction of hypotension, natriuresis and diuresis, etc.
-
Molecular Weight
- 72 kDa
Target
-
You are here:
